13
Validation of a tiered approach to aggregate exposure modelling [email protected] Project B7-ETHZ CEFIC LRI 2014 Annual Meeting

Validation of a tiered approach to aggregate exposure …cefic-lri.org/wp-content/uploads/2014/03/von-Goetz_CEFIC...Validation of a tiered approach to aggregate exposure modelling

Embed Size (px)

Citation preview

Validation of a tiered approach to aggregate exposure modelling

[email protected]

Project B7-ETHZ

CEFIC LRI 2014 Annual Meeting

Universität Zürich | 06 December 2013 | XeRR annual meeting

2

Introduction

Project team and structure

Steering board Bruno Hubesch, CEFIC-LRI Chris Money, ExxonMobil Carlos Rodriguez, P&G

Project Leader/Manager Dr. Natalie von Goetz, ETH

Team 1

(Guidance and modelling)

Team 2

(Questionnaire and biomonitoring)

Team 3 T

(Modelling and validation)

Other stakeholders Cosmetics Europe Dow Corning Corp. Unilever

1 of 9 [email protected] CEFIC LRI 2014 Annual Meeting

WP1 WP2 WP3

Universität Zürich | 06 December 2013 | XeRR annual meeting

3

Introduction 2 of 9

Motivation >89 million unique chemicals (CAS registry, 2014) Aggregate exposure – multi-source and multi-route Tier 1 tools are available (ECETOC TRA, A.I.S.E. REACT) Methodologies for realistic assessment are required

Consumer products

Pharmaceuticals

Housing & construction

Energy

Agriculture & Food

Electronics [email protected] CEFIC LRI 2014 Annual Meeting

Universität Zürich | 06 December 2013 | XeRR annual meeting

4

Aggregate consumer exposure modelling

HIGHER TIER assessment

! Adequate aggregation strategy §  Person-oriented approach – authentic robust input data (e.g. products co-use)

§  Toxicokinetics – aggregation over different routes on an appropriate timescale

! Validation piece is missing

ü  Retention

ü  Residue transfer

ü  Inadvertent ingestion

ü  Indoor air conc.

[email protected] CEFIC LRI 2014 Annual Meeting 3 of 9

Universität Zürich | 06 December 2013 | XeRR annual meeting

5

Higher Tier exposure model (PACEM)

Introduction

Product database

§  Fraction of a substance that is available for further intake as a result of product application

§  Is either a point value or frequency distribution

Questionnaire database

! intake !

[email protected] CEFIC LRI 2014 Annual Meeting 4 of 9

(Biesterbos et al., 2013)

(Dudzina et al., 2013)

! Aggregation per individual per day !

Universität Zürich | 06 December 2013 | XeRR annual meeting

6

Evaluation of tiered approach (WP3)

Introduction

5.5-fold

toothpaste

lipstick/lipbalm

10-fold

[email protected] CEFIC LRI 2014 Annual Meeting 5 of 9

Properties

Molar mass [g/mol] 371

Vapor pressure at 25C [Pa]

33.2

logKow 8.0

Effect on the environment vPvB

LOAEL [mg/kg_bw/day] 100

NOAEL [ppm] 150

D5 case-study

Universität Zürich | 06 December 2013 | XeRR annual meeting

7

Validation of tiered approach (WP3)

[email protected] CEFIC LRI 2014 Annual Meeting

(Pieri et al., 2013)

Baseline D5 concentrations in end-exhaled air

from 15 volunteers (Biesterbos et al., 2014)

Baseline D5 concentrations in blood plasma from 94 women

(Hanssen et al., 2013)

6 of 9

Indoor air concentrations

Universität Zürich | 06 December 2013 | XeRR annual meeting

8

Population HBM data

[email protected] CEFIC LRI 2014 Annual Meeting 7 of 9

Validation exercise

Universität Zürich | 06 December 2013 | XeRR annual meeting

9

Individual HBM data (WP2)

[email protected] CEFIC LRI 2014 Annual Meeting 8 of 9

1 2 3 4 5 6 7 8 9 10 11 12 13 14 150

5000

10000

15000

20000

25000

30000

35000

40000

45000

50000

D4D5Women

Men

Volunteer

Con

cent

ratio

n in

end

-exh

aled

air

(ng/

m3 )

Panel biomonitoring study with 5 men

and 10 women

End-exhaled air analysis (GC-TD-MS)

after normal use of personal care

products (24h product use diaries)

A B C D E F G H I J X K Y L M

?

Validation exercise

Universität Zürich | 06 December 2013 | XeRR annual meeting

10

Key findings

!  Person-oriented approach allows more realistic aggregate consumer exposure modelling, BUT...

n  Need for robust high-quality data n  Not necessarily applicable to other sectors of consumer products

!  Individual-based HBM data enable robust validation of exposure predictions

!  Main challenges for validation:

n  Aggregate multi-route exposure n  Identify dominant sources n  Consider time intervals between single exposure events relative to elimination half-life

(relevant for short-lived biomarkers)

[email protected] CEFIC LRI 2014 Annual Meeting 9 of 9

Universität Zürich | 06 December 2013 | XeRR annual meeting

11

Thank you

Dr. Natalie von Götz [email protected]

Christiaan Delmaar Martine Bakker Bas Bokkers Jacqueline van Engelen

Jacqueline Biesterbos Paul Scheepers Nel Roelveld

Universität Zürich | 06 December 2013 | XeRR annual meeting

12

PACEM uncertainty analysis

Introduction

Input parameter  

use amounts   1.2   14.4  

use frequencies   1.1   10.0  

D5 concentrations   2.5   24.9  

eFs   1.1   12.1  

ALL together   4.5   38.9  

Input parameter  

use amounts   1.2   14.4  use frequencies   1.1   10.0  D5 concentrations   2.5   24.9  eFs   1.1   12.1  ALL together   4.5   38.9  

Universität Zürich | 06 December 2013 | XeRR annual meeting

13

Perfume_spray